These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Leading the Way by Adopting Safe Medication Practices Associated With Abbreviation Use. Zrelak PA J Neurosci Nurs; 2018 Jun; 50(3):121-122. PubMed ID: 29727389 [No Abstract] [Full Text] [Related]
31. The thrombolysis in myocardial infarction (TIMI) trial. Ganz W N Engl J Med; 1985 Oct; 313(16):1018. PubMed ID: 3930960 [No Abstract] [Full Text] [Related]
32. Tenecteplase: single-bolus thrombolytic therapy for acute myocardial infarction. McGahan L Issues Emerg Health Technol; 2001 Jan; (13):1-6. PubMed ID: 11902221 [No Abstract] [Full Text] [Related]
33. Tenecteplase: a promising new fibrinolytic agent. De Jong MJ; Sabadie-Garretson W Dimens Crit Care Nurs; 2001; 20(6):19-23. PubMed ID: 22076580 [TBL] [Abstract][Full Text] [Related]
34. Microparticle-linked tissue factor activity and increased thrombin activity play a potential role in fibrinolysis failure in ST-segment elevation myocardial infarction. Huisse MG; Ajzenberg N; Feldman L; Guillin MC; Steg PG Thromb Haemost; 2009 Apr; 101(4):734-40. PubMed ID: 19350119 [TBL] [Abstract][Full Text] [Related]
35. Effect of combined administration of saruplase and single-chain alteplase on coronary recanalization in acute myocardial infarction. Tranchesi B; Bellotti G; Chamone DF; Verstraete M Am J Cardiol; 1989 Jul; 64(3):229-32. PubMed ID: 2500842 [No Abstract] [Full Text] [Related]